248 related articles for article (PubMed ID: 31674304)
1. Global Surveillance of trans-Fatty Acids.
Li C; Cobb LK; Vesper HW; Asma S
Prev Chronic Dis; 2019 Oct; 16():E147. PubMed ID: 31674304
[TBL] [Abstract][Full Text] [Related]
2. Contribution of Trans-Fatty Acid Intake to Coronary Heart Disease Burden in Australia: A Modelling Study.
Wu JH; Zheng M; Catterall E; Downs S; Thomas B; Veerman L; Barendregt JJ
Nutrients; 2017 Jan; 9(1):. PubMed ID: 28106762
[TBL] [Abstract][Full Text] [Related]
3. Consumption of trans fats and estimated effects on coronary heart disease in Iran.
Mozaffarian D; Abdollahi M; Campos H; Houshiarrad A; Willett WC
Eur J Clin Nutr; 2007 Aug; 61(8):1004-10. PubMed ID: 17268422
[TBL] [Abstract][Full Text] [Related]
4. Intake of ruminant trans fatty acids and risk of coronary heart disease-an overview.
Jakobsen MU; Bysted A; Andersen NL; Heitmann BL; Hartkopp HB; Leth T; Overvad K; Dyerberg J
Atheroscler Suppl; 2006 May; 7(2):9-11. PubMed ID: 16713389
[TBL] [Abstract][Full Text] [Related]
5. Impact of Nonoptimal Intakes of Saturated, Polyunsaturated, and Trans Fat on Global Burdens of Coronary Heart Disease.
Wang Q; Afshin A; Yakoob MY; Singh GM; Rehm CD; Khatibzadeh S; Micha R; Shi P; Mozaffarian D;
J Am Heart Assoc; 2016 Jan; 5(1):. PubMed ID: 26790695
[TBL] [Abstract][Full Text] [Related]
6. Consumption of industrial and ruminant trans fatty acids and risk of coronary heart disease: a systematic review and meta-analysis of cohort studies.
Bendsen NT; Christensen R; Bartels EM; Astrup A
Eur J Clin Nutr; 2011 Jul; 65(7):773-83. PubMed ID: 21427742
[TBL] [Abstract][Full Text] [Related]
7. Development and application of the TFA macrosimulation model: a case study of modelling the impact of trans fatty acid (TFA) elimination policies in Brazil.
Nilson EAF; Khandpur N; da Silva Gomes F
BMC Public Health; 2022 Nov; 22(1):2010. PubMed ID: 36324096
[TBL] [Abstract][Full Text] [Related]
8. A cross-sectional study on trans-fatty acids and risk markers of CHD among middle-aged men representing a broad range of BMI.
Nielsen BM; Nielsen MM; Jakobsen MU; Nielsen CJ; Holst C; Larsen TM; Bendsen NT; Bysted A; Leth T; Hougaard DM; Skogstrand K; Astrup A; Sørensen TI; Jess T
Br J Nutr; 2011 Oct; 106(8):1245-52. PubMed ID: 21736833
[TBL] [Abstract][Full Text] [Related]
9. Intake of ruminant trans fatty acids and risk of coronary heart disease.
Jakobsen MU; Overvad K; Dyerberg J; Heitmann BL
Int J Epidemiol; 2008 Feb; 37(1):173-82. PubMed ID: 18077475
[TBL] [Abstract][Full Text] [Related]
10. Eliminating artificial trans fatty acids in Argentina: estimated effects on the burden of coronary heart disease and costs.
Rubinstein A; Elorriaga N; Garay OU; Poggio R; Caporale J; Matta MG; Augustovski F; Pichon-Riviere A; Mozaffarian D
Bull World Health Organ; 2015 Sep; 93(9):614-22. PubMed ID: 26478625
[TBL] [Abstract][Full Text] [Related]
11. Trans fatty acids and cardiovascular health: translation of the evidence base.
Booker CS; Mann JI
Nutr Metab Cardiovasc Dis; 2008 Jul; 18(6):448-56. PubMed ID: 18468872
[TBL] [Abstract][Full Text] [Related]
12. Serum Trans Fatty Acids Are Not Associated with Weight Gain or Linear Growth in School-Age Children.
Baylin A; Perng W; Mora-Plazas M; Marin C; Villamor E
J Nutr; 2015 Sep; 145(9):2102-8. PubMed ID: 26180252
[TBL] [Abstract][Full Text] [Related]
13. Analysis of Fat Content with Special Emphasis on Trans Isomers in Frequently Consumed Food Products in Egypt: The First Steps in the Trans Fatty Acid Elimination Roadmap.
Ismail G; Abo El Naga R; El Sayed Zaki M; Jabbour J; Al-Jawaldeh A
Nutrients; 2021 Sep; 13(9):. PubMed ID: 34578964
[TBL] [Abstract][Full Text] [Related]
14. Impact of Austria's 2009 trans fatty acids regulation on all-cause, cardiovascular and coronary heart disease mortality.
Grabovac I; Hochfellner L; Rieger M; Jewell J; Snell A; Weber A; Stüger HP; Schindler KE; Mikkelsen B; Dorner TE
Eur J Public Health; 2018 Oct; 28(suppl_2):4-9. PubMed ID: 30371837
[TBL] [Abstract][Full Text] [Related]
15. Health effects of trans-fatty acids: experimental and observational evidence.
Mozaffarian D; Aro A; Willett WC
Eur J Clin Nutr; 2009 May; 63 Suppl 2():S5-21. PubMed ID: 19424218
[TBL] [Abstract][Full Text] [Related]
16. Trans-fatty Acids and Survival in Renal Transplantation.
Chandra A; Svensson M; Åsberg A; Schmidt EB; Bjerve KS; Jenssen T; Hartmann A; Ueland T; Eide IA
J Ren Nutr; 2019 May; 29(3):169-180. PubMed ID: 30309780
[TBL] [Abstract][Full Text] [Related]
17. Consumption and health effects of trans fatty acids: a review.
Teegala SM; Willett WC; Mozaffarian D
J AOAC Int; 2009; 92(5):1250-7. PubMed ID: 19916363
[TBL] [Abstract][Full Text] [Related]
18. Serum trans fatty acids, asymmetric dimethylarginine and risk of acute myocardial infarction and mortality in patients with suspected coronary heart disease: a prospective cohort study.
Borgeraas H; Hertel JK; Seifert R; Berge RK; Bohov P; Ueland PM; Nygård O; Hjelmesæth J
Lipids Health Dis; 2016 Feb; 15():38. PubMed ID: 26920731
[TBL] [Abstract][Full Text] [Related]
19. trans Isomeric fatty acids are inversely related to the availability of long-chain PUFAs in the perinatal period.
Decsi T; Boehm G
Am J Clin Nutr; 2013 Aug; 98(2):543S-8S. PubMed ID: 23824720
[TBL] [Abstract][Full Text] [Related]
20. Estimated health benefits, costs, and cost-effectiveness of eliminating industrial trans-fatty acids in Australia: A modelling study.
Marklund M; Zheng M; Veerman JL; Wu JHY
PLoS Med; 2020 Nov; 17(11):e1003407. PubMed ID: 33137090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
